It has not been until recently that two genes located outside the HLA region, the interleukin-2 receptor α (IL2RA) and the interleukin-7 receptor α (IL7RA), have been proposed as strong candidates for MS susceptibility in several studies [5]–[7]. The gene discussed is IL2RA; the disease is myeloid sarcoma.